Sinovac regimen gets strong boost from Pfizer, AstraZeneca or J&J COVID shots - study

United States News News

Sinovac regimen gets strong boost from Pfizer, AstraZeneca or J&J COVID shots - study
United States Latest News,United States Headlines
  • 📰 ReutersScience
  • ⏱ Reading Time:
  • 12 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 51%

A third booster dose of a COVID-19 vaccine made by AstraZeneca, Pfizer-BioNTech or Johnson & Johnson increases antibody levels significantly in those who have previously received two doses of Sinovac's CoronaVac shot, a study has found.

Vials of Chinese Sinovac's CoronaVac vaccine against coronavirus disease pictured inside the newly inaugurated production lab designated to manufacture the vaccine, in Constantine, Algeria September 29, 2021.

However, another study in December found that Sinovac's two-dose shot followed by a booster dose of Pfizer-BioNTech's vaccine showed a lower immune response against the Omicron variant compared with other strains.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ReutersScience /  🏆 559. in US

United States Latest News, United States Headlines



Render Time: 2025-02-24 18:26:22